Published in Science on July 25, 1997
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci (2007) 7.77
Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev (1998) 3.24
Cell death in the nervous system. Nature (2006) 2.62
Molecular control of bacterial death and lysis. Microbiol Mol Biol Rev (2008) 2.52
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci U S A (2006) 1.90
Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2000) 1.72
Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci U S A (1998) 1.55
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest (2004) 1.41
The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion (2011) 1.40
Clinical and experimental applications of sodium phenylbutyrate. Drugs R D (2011) 1.32
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet (2010) 1.31
Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis (2009) 1.29
Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta (2009) 1.27
Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest (2005) 1.19
Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest (2003) 1.17
Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol Cell Proteomics (2004) 1.17
Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J Neurosci (2007) 1.15
Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J Clin Invest (2010) 1.11
Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci U S A (1998) 1.11
Neurodegeneration: what is it and where are we? J Clin Invest (2003) 1.11
ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci (2014) 1.10
Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk. J Neurosci (2009) 1.10
Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. PLoS One (2010) 1.09
Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol (2009) 1.09
The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J (2003) 1.04
Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav (2013) 1.03
The executioners sing a new song: killer caspases activate microglia. Cell Death Differ (2011) 1.02
Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation. Cell Mol Neurobiol (2008) 1.01
Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain (2011) 1.00
Motor neuron trophic factors: therapeutic use in ALS? Brain Res Rev (2010) 0.98
IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ (2010) 0.98
CED-9 and mitochondrial homeostasis in C. elegans muscle. J Cell Sci (2008) 0.97
Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells. FEBS J (2010) 0.95
Angiogenin inhibits nuclear translocation of apoptosis inducing factor in a Bcl-2-dependent manner. J Cell Physiol (2012) 0.94
Stimulation-induced mitochondrial [Ca2+] elevations in mouse motor terminals: comparison of wild-type with SOD1-G93A. J Physiol (2003) 0.92
Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav (2013) 0.91
Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep (2012) 0.90
Motor neurone disease. BMJ (1999) 0.88
Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases. J Cell Physiol (2016) 0.87
Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am J Pathol (2010) 0.86
Genetic modulation of apoptotic pathways fails to alter disease course in tripeptidyl-peptidase 1 deficient mice. Neurosci Lett (2009) 0.84
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2013) 0.83
BAFF controls neural cell survival through BAFF receptor. PLoS One (2013) 0.83
ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proc Natl Acad Sci U S A (2014) 0.81
Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration. Curr Biol (2016) 0.79
Mutant CuZn superoxide dismutase in motor neuron disease. J Inherit Metab Dis (1998) 0.78
Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progress. Toxins (Basel) (2010) 0.78
Early intervention in bipolar disorder, part II: therapeutics. Early Interv Psychiatry (2008) 0.76
Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid. Int J Mol Sci (2016) 0.75
Treatment of amyotrophic lateral sclerosis--what is the next step? J Neurol (2000) 0.75
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med (1999) 4.88
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 3.12
Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 2.84
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration (1995) 2.71
VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci U S A (1997) 2.34
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem (2001) 2.18
The DBP gene is expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences circadian behavior. EMBO J (1997) 2.17
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A (1996) 2.10
Motor blocks in Parkinson's disease. Neurology (1992) 2.01
Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology (2001) 1.94
The metabolic topography of parkinsonism. J Cereb Blood Flow Metab (1994) 1.89
Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A (1999) 1.88
The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci (1992) 1.79
Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res (1991) 1.76
Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci U S A (1998) 1.71
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 1.62
Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci (1995) 1.61
Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A (1998) 1.59
Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem (1999) 1.56
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol (2001) 1.55
Metabolic correlates of levodopa response in Parkinson's disease. Neurology (2001) 1.50
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem (2000) 1.49
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis (2001) 1.48
Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res (1988) 1.46
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet (2001) 1.42
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid. Acta Neurol Scand (1990) 1.41
Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology (1991) 1.41
Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience (1995) 1.37
The role of glial cells in Parkinson's disease. Curr Opin Neurol (2001) 1.36
Mechanisms of MPTP toxicity. Mov Disord (1998) 1.35
Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci (2001) 1.35
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol (2000) 1.22
Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J Biol Chem (2001) 1.22
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell (2001) 1.21
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem (2001) 1.20
D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci (1998) 1.20
Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci (1989) 1.16
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology (1995) 1.16
Extra-hypothalamic afferent inputs to the supraoptic nucleus area of the rat as determined by retrograde and anterograde tracing techniques. Neuroscience (1985) 1.13
Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol (2000) 1.12
Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem (1999) 1.12
COX-2 and neurodegeneration in Parkinson's disease. Ann N Y Acad Sci (2003) 1.11
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration (1995) 1.11
Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice. Exp Neurol (1994) 1.04
Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder. Int J Geriatr Psychiatry (2011) 1.03
Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice. Neuroscience (2000) 1.02
Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology (2002) 1.02
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res (1999) 1.02
Isolated palsy of the superior branch of the oculomotor nerve due to chronic erosive sphenoid sinusitis. J Clin Neuroophthalmol (1993) 1.01
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res (1989) 1.00
The metabolic topography of idiopathic torsion dystonia. Brain (1995) 1.00
Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci (1992) 0.99
Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci (2000) 0.98
Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci (1995) 0.97
Neurons in the dorsal motor nucleus of the vagus nerve are excited by oxytocin in the rat but not in the guinea pig. Proc Natl Acad Sci U S A (1987) 0.96
Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol (1998) 0.95
Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov Disord (1999) 0.95
Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol (1997) 0.95
Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem (1997) 0.92
Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Brain Res Dev Brain Res (1991) 0.92
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann Neurol (1993) 0.92
An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats. J Neurosci Methods (1990) 0.91
Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res Bull (1991) 0.91
Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice. J Neurochem (1992) 0.91
Gonadal steroids regulate oxytocin receptors but not vasopressin receptors in the brain of male and female rats. An autoradiographical study. Brain Res (1990) 0.91
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. Eur J Neurosci (2001) 0.90
Bcl-2 and neuronal selection during development of the nervous system. J Physiol Paris (1994) 0.90
Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease. Cell Death Differ (2011) 0.90
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry (2012) 0.90
Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study. J Comp Neurol (1999) 0.89
Time course of axotomy-induced apoptotic cell death in facial motoneurons of neonatal wild type and bcl-2 transgenic mice. Neuroscience (1996) 0.88
Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5. Br J Pharmacol (2010) 0.88
Vasopressin receptors in the mouse (Mus musculus) brain: sex-related expression in the medial preoptic area and hypothalamus. Brain Res (1996) 0.86
Vasopressin receptors of the vasopressor (V1) type in the nucleus of the solitary tract of the rat mediate direct neuronal excitation. J Neurosci (1989) 0.86
Magnetic resonance imaging determinants of intraindividual variability in the elderly: combined analysis of grey and white matter. Neuroscience (2011) 0.86
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease. Mov Disord (1987) 0.85
Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia. Neurobiol Dis (2004) 0.85
Somatosensory systems and the milk-ejection reflex in the rat. II. The effects of lesions in the ventroposterior thalamic complex, dorsal columns and lateral cervical nucleus-dorsolateral funiculus. Neuroscience (1985) 0.85
Differential distribution of presenilin-1, Bax, and Bcl-X(L) in Alzheimer's disease and frontotemporal dementia. Acta Neuropathol (1999) 0.84